医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth.

广告
第一作者: Aleksandra,Fesiuk
第一单位: Department of Pathology, Medical University of Vienna, Vienna, Austria.;Christian Doppler Laboratory for Applied Metabolomics, Division of Nuclear Medicine, The Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
作者单位: Department of Pathology, Medical University of Vienna, Vienna, Austria.;Christian Doppler Laboratory for Applied Metabolomics, Division of Nuclear Medicine, The Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. [1] Department of Pathology, Medical University of Vienna, Vienna, Austria.;Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University Vienna, Vienna, Austria. [2] Department of Chemical and Physical Sciences, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga, ON, L5L 1C6, Canada.;Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON, M5S 3H6, Canada. [3] Central European Institute of Technology, Masaryk University, Brno, 62500, Czech Republic. [4] Department of Pathology, Medical University of Vienna, Vienna, Austria. [5] Unit of Laboratory Animal Pathology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria. [6] Department of Analytical Chemistry, University of Vienna, Vienna, 1090, Austria.;Doctoral School in Chemistry, University of Vienna, Vienna, 1090, Austria. [7] Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University Vienna, Vienna, Austria. [8] Department of Pathology, Medical University of Vienna, Vienna, Austria.;Department for Basic and Translational Oncology and Hematology, Division Molecular Oncology and Hematology, Karl Landsteiner University of Health Sciences, Krems, 3500, Austria. [9] Department of Pathology, Medical University of Vienna, Vienna, Austria.;St. Anna Children's Cancer Research Institute, Innovative Cancer Models, Vienna, Austria. [10] Department of Physical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, 4032, Hungary. [11] Centre for Biological Sciences, University of Veterinary Medicine, Vienna, Austria. [12] Institute of in vivo and in vitro Models, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Veterinärplatz 1, Vienna, 1210, Austria. [13] Institute for Pathophysiology and Allergy Research, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria. [14] Centre for Cancer Research and Cell Biology, Almac Diagnostics, Queens University Belfast, Northern Ireland, Northern Ireland, Craigavon, United Kingdom. [15] Department of Biosciences & Medical Biology, Paris Lodron University of Salzburg, Salzburg, Austria. [16] School of Biomedical Sciences, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. [17] Division of Experimental Cancer Research, Department of Translational Medicine, Clinical Research Centre, Lund University, Malmö, Sweden.;Department of Molecular Biology, Umeå University, Umeå, Sweden. [18] Department of Analytical Chemistry, University of Vienna, Vienna, 1090, Austria.;Joint Metabolome Facility, University of Vienna, Vienna, 1090, Austria. [19] Division of Biomolecular Science and Medicinal Chemistry, School of Pharmacy, BioDiscovery Institute, University of Nottingham, Nottingham, UK. [20] Department of Pathology, Medical University of Vienna, Vienna, Austria. olaf.merkel@meduniwien.ac.at.;European Research Initiative on ALK-Related Malignancies (ERIA), Cambridge, UK. olaf.merkel@meduniwien.ac.at. [21] Department of Pathology, Medical University of Vienna, Vienna, Austria. brigitte.hantusch@meduniwien.ac.at. [22] Department of Pathology, Medical University of Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.;Christian Doppler Laboratory for Applied Metabolomics, Division of Nuclear Medicine, The Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.;Unit of Laboratory Animal Pathology, Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at.;Department of Molecular Biology, Umeå University, Umeå, Sweden. lukas.kenner@meduniwien.ac.at.;Center for Biomarker Research in Medicine (CBmed), Graz, Austria. lukas.kenner@meduniwien.ac.at.;Comprehensive Cancer Center, Medical University Vienna, Vienna, Austria. lukas.kenner@meduniwien.ac.at. [23]
DOI 10.1186/s12943-025-02451-2
PMID 41088246
发布时间 2025-10-17
提交
  • 浏览1
Molecular cancer

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷